Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model

Regenerative Medicine

Volumn 6, Issue 2, 2011, Pages 179-190

  Wang, Wei ^a,b   Jiang, Qin ^a   Zhang, Hao ^a   Jin, Peifeng ^a   Yuan, Xin ^a   Wei, Yingjie ^a   Hu, Shengshou ^a  

^a FUWAI HOSPITAL   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

bone marrow mesenchymal stromal cells; chronic myocardial infarction; heart; lung; rat

Indexed keywords

BROXURIDINE; INTERLEUKIN 1BETA; MALONALDEHYDE; MYELOPEROXIDASE; PHOSPHATE BUFFERED SALINE; TUMOR NECROSIS FACTOR ALPHA;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW MESENCHYMAL STROMAL CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL FATE; CELL MIGRATION; CELLULAR DISTRIBUTION; CHRONIC MYOCARDIAL INFARCTION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE MODEL; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION TEST; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS EPITHELIUM; LUNG FUNCTION TEST; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM;

ANIMALS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; INJECTIONS, INTRAVENOUS; LUNG; LUNG DISEASES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY FUNCTION TESTS; STROMAL CELLS;

EID: 79952592481     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.10.104     Document Type: Article

References (34)

1. Yamahara K, Nagaya N: Mesenchymal stem cells for the treatment of heart disease. Regen. Med. 2(2), 107-109 (2007). (Pubitemid 46831075)
2. Huang NF, Li S: Mesenchymal stem cells for vascular regeneration. Regen. Med. 3(6), 877-892 (2008).
3. van Ramshorst J, Bax JJ, Beeres SL et al.: Intramyocardial bone marrow cel injection for chronic myocardial ischemia: a randomized controlled trial. JAMA 301(19), 1997-2004 (2009).
4. Losordo DW, Schatz RA, White CJ et al.: Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a Phase I/IIa double-blind, randomized controlled trial. Circulation 115(25), 3165-3172 (2007). (Pubitemid 47018140)
5. Hare JM, Traverse JH, Henry TD et al.: A randomized, double-blind, placebocontrolled, dose-escalation study of intravenous adult human mesenchymal stem cells (Prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54(24), 2277-2286 (2009).
6. Boomsma RA, Swaminathan PD, Geenen DL: Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size. Int. J. Cardiol. 122(1), 17-28 (2007). (Pubitemid 47503347)
7. Lee RH, Pulin AA, Seo MJ et al.: Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5(1), 54-63(2009).
8. Wang F, Guan J: Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy. Adv. Drug Deliv. Rev. 62(7-8), 784-797 (2010).
9. Hou M, Yang KM, Zhang H et al.: Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats. Int. J. Cardiol. 115(2), 220-228 (2007). (Pubitemid 46157045)
10. Zhang H, Fazel S, Tian H et al.: Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. Am. J. Physiol. Heart Circ. Physiol. 289(5), H2089-H2096 (2005). (Pubitemid 41507361)
11. Su W, Zhang H, Jia Z, Zhou C, Wei Y, Hu S: Cartilage-derived stromal cells: is it a novel cell resource for cell therapy to regenerate infarcted myocardium? Stem Cells 24(2), 349-356 (2006). (Pubitemid 44464804)
12. Xin Y, Wang YM, Zhang H et al.: Aging adversely impacts biological properties of human bone marrow-derived mesenchymal stem cells: implications for tissue engineering heart valve construction. Artif. Organs 34(3), 215-222 (2010).
13. Zhang H, Zhu SJ, Wang W, Wei YJ, Hu SS: Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function. Gene Ther. 15(1), 40-48 (2008). (Pubitemid 350269431)
14. Chu SJ, Lee TY, Yan HC, Lin SH, Li MH: l-Arginine prevents air embolism-induced acute lung injury in rats. Crit. Care Med. 33(9), 2056-2060 (2005).
15. Li MH, Huang KL, Wu SY et al.: Baicalin attenuates air embolism-induced acute lung injury in rat isolated lungs. Br. J. Pharmacol. 157(2), 244-251 (2009).
16. Kinoshita M, Ono S, Mochizuki H: Neutrophils mediate acute lung injury in rabbits: role of neutrophil elastase. Eur. Surg. Res. 32(6), 337-346 (2000). (Pubitemid 32153912)
17. Song P, Zhang H, Lu MJ et al.: Role of cardiopulmonary bypass and arrested heart status in the early cell distribution after intracoronary infusion of bone marrow stromal cells. J. Surg. Res. 153(1), 66-70(2009).
18. Dai W, Hale SL, Martin BJ et al.: Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short-and long-term effects. Circulation 112(2), 214-223 (2005). (Pubitemid 40982304)
19. Dimmeler S, Burchfield J, Zeiher AM: Cell-based therapy of myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 28(2), 208-216 (2008). (Pubitemid 351161191)
20. Sherman W, Martens TP, Viles-Gonzalez JF, Siminiak T: Catheter-based delivery of cells to the heart. Nat. Clin. Pract. Cardiovasc. Med. 3(Suppl. 1), S57-S64 (2006).
21. Barbash IM, Chouraqui P, Baron J et al.: Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108(7), 863-868 (2003). (Pubitemid 37022130)
22. Fischer UM, Harting MT, Jimenez F et al.: Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 18(5), 683-692 (2009).
23. Li SH, Lai TY, Sun Z et al.: Tracking cardiac engraftment and distribution of implanted bone marrow cells: comparing intra-aortic, intravenous, and intramyocardial delivery. J. Thorac. Cardiovasc. Surg. 137(5), 1225-1233 e1221(2009).
24. Al Kindi A, Ge Y, Shum-Tim D, Chiu RC: Cellular cardiomyoplasty: routes of cell delivery and retention. Front Biosci. 13, 2421-2434 (2008). (Pubitemid 351599695)
25. Toma C, Wagner WR, Bowry S et al.: Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics. Circ. Res. 104(3), 398-402 (2009).
26. Card JW, Zeldin DC, Bonner JC, Nestmann ER: Pulmonary applications and toxicity of engineered nanoparticles. Am. J. Physiol. Lung Cell Mol. Physiol. 295(3), L400-L411(2008).
27. Loebinger MR, Janes SM: Stem cells for lung disease. Chest 132(1), 279-285 (2007). (Pubitemid 47068232)
28. Wong AP, Keating A, Lu WY et al.: Identification of a bone marrow-derived epithelial-like population capable of repopulating injured mouse airway epithelium. J. Clin. Invest. 119(2), 336-348 (2009).
29. Milner CM, Higman VA, Day AJ: TSG-6: a pluripotent inflammatory mediator? Biochem. Soc. Trans. 34(Pt 3), 446-450 (2006). (Pubitemid 43954008)
30. Oh JY, Roddy GW, Choi H et al.: Antiinflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc. Natl Acad. Sci. USA 107(39), 16875-16880 (2010).
31. Fang L, Gao XM, Moore XL et al.: Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J. Mol. Cell Cardiol. 43(5), 535-544 (2007). (Pubitemid 47615041)
32. Paolocci N, Tavazzi B, Biondi R et al.: Metalloproteinase inhibitor counters high-energy phosphate depletion and AMP deaminase activity enhancing ventricular diastolic compliance in subacute heart failure. J. Pharmacol. Exp. Ther. 317(2), 506-513 (2006).
33. Salem HK, Thiemermann C: Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28(3), 585-596 (2010).
34. Harting MT, Jimenez F, Xue H et al.: Intravenous mesenchymal stem cell therapy for traumatic brain injury. J. Neurosurg. 110(6), 1189-1197 (2009).